Virtu Financial’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Virtu Financial’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,038	Closed	-$44K	–	2497
2022 Q3	$44K	Buy	6,038 +4,944	+452%	+$60.1K	﹤0.01%	1234
2022 Q2	$14K	Buy	+1,094	New	+$10.3K	﹤0.01%	1394
2020 Q4	–	Sell	-67	Closed	-$4K	–	1917
2020 Q3	$4K	Buy	+67	New	+$5.99K	﹤0.01%	972
2019 Q4	$22K	Sell	178 -17	-9%	-$2.3K	﹤0.01%	1316
2019 Q3	$23K	Buy	195 +22	+13%	+$4.43K	﹤0.01%	1279
2019 Q2	$52K	Buy	+173	New	+$72.2K	﹤0.01%	1226
2019 Q1	–	Sell	-179	Closed	-$82K	–	2005
2018 Q4	$82K	Sell	179 -58	-24%	-$36K	﹤0.01%	1183
2018 Q3	$215K	Buy	+237	New	+$156K	0.01%	1048
2018 Q2	–	Sell	-435	Closed	-$284K	–	2649
2018 Q1	$284K	Buy	+435	New	+$327K	0.02%	1093
2017 Q4	–	Sell	-351	Closed	-$107K	–	3189
2017 Q3	$107K	Buy	+351	New	+$133K	0.01%	2059

Other funds holding HTGM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Virtu Financial's HTGM Position: Q4 2022 in Review

Virtu Financial sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2022, closing a stake of 6,038 shares — an estimated $44K sold.

Virtu Financial first reported a position in HTGM in Q3 2017 and held it in 10 quarters. The position peaked at $284K in Q1 2018. 10 funds tracked by Wall St. Rank hold HTGM as of Q4 2022.

Virtu Financial reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 6,038 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2022, an estimated $44K.
Virtu Financial first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q3 2017 and held it in 10 quarters.
Virtu Financial's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $284K in Q1 2018.
10 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.